News
CEPI and Moderna Harness mRNA Technology to Advance 100 Days Mission
New partnership will harness Moderna’s mRNA rapid-response platform, clinically validated during the COVID-19 pandemic, to accelerate epidemic and pandemic vaccine development
First project
3 hot mid-caps set to report Q3 earnings
Up as much as 13% earlier this year, the S&P 400 has slipped into negative territory for 2023. Like its large-cap cousin, the S&P 500, the mid-cap index is being weighed down by surging Treasury
Why These 3 Equal-Weighted ETFs Deserve a Portfolio Spot
In the investing world, not all exchange-traded funds (ETFs) are created equal. Quite literally, most aren’t.
Most ETFs use a market capitalization weighting scheme to determine how much gets
Analysts Recommend These Stocks To Cushion The Automotive Slump
By now, most market participants are aware of the UAW (United Auto Workers) union strikes, which pose a significant risk to domestic auto manufacturers and their profitability. That is about as
Challenges Loom for Regional Banks as Interest Rates Surge
As the big banks begin reporting earnings, will investors get some insights into whether higher interest rates will mean pressure on profits.
First up are JPMorgan Chase & Co. (NYSE: JPM), Wells
MongoDB Is Well-Positioned For Growth as AI Use Increases
Database specialist MongoDB Inc. (NASDAQ: MDB) has been forming a double-bottom base with a buy point above $414. Within its industry, the stock’s price performance is about equal with Splunk Inc.
5 Reasons Gilead Sciences is a Better Buy Than You Think
Shares of Gilead Sciences (NASDAQ: GILD) are down roughly 20% from their highs in 2023 and, like other stocks in correction this year, are showing signs of a bottom. The price pressure in 2023 is
Jobs Are Going To The Construction Industry, Momentum Play Time
When an industry decides to go on a hiring spree, you better bet on the respective firms' overall management to expect a surge of demand - and, therefore, profits - coming right around the corner
Time to Clean Up with These 3 Profitable Garbage Stocks
If there's one thing that will continue to compound and swell for as long as there are cities, communities and towns, it’s garbage. Trash, waste, junk, litter, rubbish, muck, and refuse colorfully
5 of the Most Active Penny Stocks Worth Your Precious Time
Penny stocks can be a treasure trove of investment opportunities, and the list of Most Active Penny Stocks is a good place to start looking. The downside is that many penny stocks are active for
Tip The Risk / Reward Scale In your Favor With These 3 Names
Widely watched inflation indicators have proved to be more persistent than initially thought, making the argument from the FED chairman, Jerome Powell, a shrug from the past year. Inflation has
3 Stocks For the Resurgent Energy Rally
The oil and gas machinery and equipment industry has been rising up the ranks this year in terms of aggregate price.
While two very small stocks, Geospace Technologies Corp. (NASDAQ: GEOS) and
Are the S&P 500's Biggest Q3 Losers Next Year's Winners?
What started out to be a promising third quarter for U.S. stocks turned into a dud. On the backs of artificial intelligence (AI) excitement, the S&P 500 stormed out of the gates in July only to
5 Reasons Why Arcos Dorados Is A Perfect Investment for 2024
Arcos Dorados (NYSE: ARCO) is worth a look if you are looking for a perfect place to position money for 2024. The company is a significant player in a growing industry; it has emerging market
Energy Stocks Shine as High Oil Prices Boost Dividend Yields
Bond yields are rising, which could make fixed-income attractive, but many investors prefer to hold dividend-paying equities as they have higher growth potential.
Those higher bond yields mean
AI Boosts Duolingo As Company Posts First Profit
When it comes to AI, language-learning app Duolingo Inc. (NYSE: DUOL) is articulating the idea, “If you can’t beat ’em, join ’em.” The approach seems to be working.
The company embraced AI early
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
JetBlue Airways Corporation (NASDAQ: JBLU) stock is selling for peanuts.
On Friday, shares of the low-fare airline fell to their lowest level since 2012. Trading below $5.00, Jet’s Blue’s second
Etsy Gets an Upgrade and $100 Target...Is the Bottom Finally In?
When Etsy, Inc. (NASDAQ:ETSY) shares dipped to a three-year low last week, Wolfe Research decided it was time for an upgrade.
On September 12th, the sell-side research firm bumped its rating on
3 Reasons Wall Street Is 100% Bullish on This Recent IPO
Known for keeping money in consumer pockets, Savers Value Village, Inc. (NYSE: SVV) may soon be putting money in investor accounts.
North America’s biggest for-profit thrift store operator
5 eCommerce Companies that need to be on Your Watch List
The retail environment is challenging, and there are weaknesses to be aware of. Shifting consumer habits have them focused on dailies, health & beauty more than discretionary items, which impacts
Could Ely Lilly Be the Best Pharma Stock to Own Now and Forever?
Pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) stock has been on a tear, trading up 57.7% year-to-date (YTD). The company is firing on all cylinders with its leading medications and a highly
2 Wrecked Stocks Keeping Cars on the Road Ready for Repair
Rising oil prices and the cooling vehicle market have one thing in common: cars. Both developments impact vehicle sales and usage. Vehicle maintenance, service and repair companies keep cars on
EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s Updated Covid-19 Vaccine in The European Union
The positive opinion follows the recommendation from regulators and global public health bodies to develop monovalent XBB.1.5 COVID-19 vaccines for autumn/winter 2023 vaccination campaigns
Der Ausschuss für Humanarzneimittel der EMA gibt positives Gutachten heraus, in dem die Zulassung des aktualisierten COVID-19-Impfstoffs von Moderna in der Europäischen Union empfohlen wird
Die positive Stellungnahme folgt der Empfehlung von Regulierungsbehörden und globalen Gesundheitsbehörden, monovalente XBB.1.5-COVID-19-Impfstoffe für Impfkampagnen im Herbst/Winter 2023 zu
Body Slammed Under $100, Is World Wrestling Stock an Opportunity?
On August 24, World Wrestling Entertainment, Inc. (NYSE: WWE) was like a beefy man in tights standing atop the ropes in preparation for a takedown. The specialty media group had just announced